U.S. FDA Launches First Overseas Office in Beijing
This article was originally published in PharmAsia News
Executive Summary
U.S. HHS Secretary Michael Leavitt and U.S. FDA Commissioner Andrew von Eschenbach officially opened the first overseas FDA office Nov. 19 in Beijing in a continuing effort to improve foreign product safety, while the agency faces criticism from the U.S. Congress
You may also be interested in...
Biden’s Visit Highlights China-U.S. Cooperation On API Oversight And Patent Protection
Last week, U.S. Vice President Joe Biden visited China, Japan, and South Korean during a six-day Asia trip. One of Biden’s goals in China was to strengthen collaboration between the two countries on food and drug safety as well as patent protection.
China 2014 Regulatory Outlook: Expect Greater Enforcement As CFDA Rolls Out New Regs
The year 2014 could see China FDA implement a series of rules, including revisions to the Drug Registration Regulation and the Medical Device Administration Regulation, which could significantly impact the pharmaceutical and medical device industries.
China 2014 Regulatory Outlook: Expect Greater Enforcement As CFDA Rolls Out New Regs
The year 2014 could see China FDA implement a series of rules, including revisions to the Drug Registration Regulation and the Medical Device Administration Regulation, which could significantly impact the pharmaceutical and medical device industries.